Gemcitabine (GEM) and vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): a phase II study in elderly or poor performance status patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples